Dow Up 1.31% Nasdaq Up 2.40%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
51.09 Up 1.75(3.55%) 4:00PM EDT
Prev Close:49.34
Open:49.77
Bid:45.00 x 100
Ask:51.40 x 100
1y Target Est:81.11
Beta:2.44
Earnings Date:Nov 3 - Nov 8 (Est.)
Day's Range:48.91 - 51.50
52wk Range:35.33 - 93.33
Volume:1,437,356
Avg Vol (3m):752,542
Market Cap:1.74B
P/E (ttm):N/A
EPS (ttm):-3.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSUp 3.55%1.74B
IMMU 0.00%339.87M
LRUSF 0.00%N/A
THLDUp 0.33%178.10M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):122.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.06
Quarterly EPS Est (Sep-14) :-1.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback